Abstract
Mutations in the LMNA gene resulting in the substitution of the highly conserved arginine 482 residue in the globular C-terminal domain of lamin A/C are associated with the Dunnigan-type familial partial lipodystrophy (FPLD2) often accompanied by impairments in the muscle tissue development. The mechanisms underlying these impairments remain unknown. The purpose of our work was to investigate the effects of the LMNA gene mutation R482L on the muscle differentiation and intramuscular fat accumulation using C2C12 mouse myoblasts transduced with the lentiviral constructs carrying the wild-type human LMNA gene (LMNA-WT) or the LMNA-R482L mutant gene. After stimulation of myogenesis and adipogenesis in the transduced cell, expression of muscle and adipose tissue differentiation markers, morphology of differentiated myotubes, and formation of intramuscular lipid droplets were analyzed. C2C12 cells carrying the LMNA-R482L construct exhibited upregulated desmin expression at all stages of muscle differentiation and transformed into hypertrophied myotubules (in comparison with C2C12 myoblasts transduced with LMNA-WT). Reduced expression levels of the myogenic transcription factor Myf6 in the cells with the LMNA-R482L mutant indicated delayed maturation of muscle fibers. These cells more actively accumulated fat in response to the stimulation of adipose differentiation than myoblasts modified with the wild-type LMNA; they also expressed the markers of lipid droplets, such as FABP4 (fatty acid-binding protein 4), ATGL (adipose triglyceride lipase), and PLIN2 (perilipin 2). Therefore, the R482L mutation of the LMNA gene affects the dynamics of C2C12 myoblast differentiation into myotubules and stimulates formation of fat deposits in the myoblasts and myotubules in a tissue-specific manner.
Similar content being viewed by others
Abbreviations
- ATGL:
-
adipose triglyceride lipase
- BSA:
-
bovine serum albumin
- DAPI:
-
4′,6-diamidino-2-phenylindol
- DM:
-
differentiating medium
- DMEM:
-
Dulbecco modified Eagle’s medium
- FABP4:
-
fatty acid-binding protein 4
- FPLD2:
-
familial partial lipodystrophy, Dunnigan type
- MSC:
-
mesenchymal stem cell
- MYH3:
-
fetal myosin
- MYMK:
-
myoblast fusion factor (myomaker)
- MyoD:
-
myogenic regulatory factor D
- PBS:
-
phosphate buffered saline
- PLIN2:
-
perilipin 2
- qPCR:
-
real-time polymerase chain reaction
- WT:
-
wild-type
References
Hutchison, C. J., and Worman, H. J. (2004) A–type lamins: guardians of the soma? Nat. Cell Biol., 6, 1062–1067.
Lin, F., and Worman, H. J. (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C, J. Biol. Chem., 268, 16321–16326.
Dubinska–Magiera, M., Zaremba–Czogalla, M., and Rzepecki, R. (2013) Muscle development, regeneration and laminopathies: how lamins or lamina–associated pro–teins can contribute to muscle development, regeneration and disease, Cell. Mol. Life Sci., 70, 2713–2741.
Schreiber, K. H., and Kennedy, B. K. (2013) When lamins go bad: nuclear structure and disease, Cell, 152, 1365–1375.
Ostlund, C., Bonne, G., Schwartz, K., and Worman, H. J. (2001) Properties of lamin A mutants found in Emery–Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan–type partial lipodystrophy, J. Cell Sci., 114, 4435–4445.
De Las Heras, J. I., Meinke, P., Batrakou, D. G., Srsen, V., Zuleger, N., Kerr, A. R., and Schirmer, E. C. (2013) Tissue specificity in the nuclear envelope supports its functional complexity, Nucleus, 4, 460–477.
Manju, K., Muralikrishna, B., and Parnaik, V. K. (2006) Expression of disease–causing lamin A mutants impairs the formation of DNA repair foci, J. Cell Sci., 119, 2704–2714.
Parnaik, V. K., and Manju, K. (2006) Laminopathies: mul–tiple disorders arising from defects in nuclear architecture, J. Biosci., 31, 405–421.
Sebillon, P., Bouchier, C., Bidot, L. D., Bonne, G., Ahamed, K., Charron, P., Drouin–Garraud, V., Millaire, A., Desrumeaux, G., Benaiche, A., Charniot, J.–C., Schwartz, K., Villard, E., and Komajda, M. (2003) Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations, J. Med. Genet., 40, 560–567.
Sehgal, P., Chaturvedi, P., Kumaran, R. I., Kumar, S., and Parnaik, V. K. (2013) Lamin A/C haploinsufficiency mod–ulates the differentiation potential of mouse fetal stem cells, PLoS One, 8, e57891.
Naetar, N., Ferraioli, S., and Foisner, R. (2017) Lamins in the nuclear interior–life outside the lamina, J. Cell Sci., 130, 2087–2096.
Speckman, R. A., Garg, A., Du, F., Bennett, L., Veile, R., Arioglu, E., Taylor, S. I., Lovett, M., and Bowcock, A. M. (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C–terminal domain of lamin A/C, Am. J. Hum. Genet., 66, 1192–1198.
Hegele, R. A., Huff, M. W., and Young, T. K (2001) Common genomic variation in LMNA modulates indexes of obesity in Inuit, J. Clin. Endocrinol. Metab., 86, 2747–2751.
Garg, A., Peshock, R. M., and Fleckenstein, J. L. (1999) Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety), J. Clin. Endocrinol. Metab., 84, 70–74.
Ji, H., Weatheral, P., Adams–Huet, B., and Garg, A. (2013) Increased skeletal muscle volume in women with familial partial lipodystrophy, Dunnigan variety, J. Clin. Endocrinol. Metab., 98, E1410–E1413.
Shackleton, S., Lloyd, D. J., Jackson, S. N. J., Evans, R., Niermeijer, M. F., Singh, B. M., Schmidt, H., Brabant, G., Kumar, S., Durrington, P. N., Gregory, S., O’Rahilly, S., and Trembath, R. C. (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy, Nat. Genet., 24, 153–156.
Vantyghem, M. C., Pigny, P., Maurage, C. A., Rouaix–Emery, N., Stojkovic, T., Cuisset, J. M., Millaire, A., Lascols, O., Vermersch, P., Wemeau, J. L., Capeau, J., and Vigouroux, J. L. (2004) Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormali–ties, J. Clin. Endocrinol. Metab., 89, 5337–5346.
Guenantin, A. C., Briand, N., Bidault, G., Afonso, P., Bereziat, V., Vatier, C., Lascols, O., Caron–Debarle, M., Capeau, J., and Vigouroux, C. (2014) Nuclear envelope–related lipodystrophies, Semin. Cell Dev. Biol., 29, 148–157.
Muchir, A., Bonne, G., van der Kooi, A. J., van Meegen, M., Baas, F., Bolhuis, P. A., de Visser, M., and Schwartz, K. (2000) Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B), Hum. Mol. Genet., 9, 1453–1459.
Boschmann, M., Engeli, S., Moro, C., Luedtke, A., Adams, F., Gorzelniak, K., Rahn, G., Mahler, A., Dobberstein, K., Kruger, A., Schmidt, S., Spuler, S., Luft, F. C., Smith, S. R., Schmidt, H. H.–J., and Jordan, J. (2010) LMNA mutations, skeletal muscle lipid metabo–lism, and insulin resistance, J. Clin. Endocrinol. Metab., 95, 1634–1643.
Malashicheva, A., Bogdanova, M., Zabirnyk, A., Smolina, N., Ignatieva, E., Freilikhman, O., Fedorov, A., Dmitrieva, R., Sjoberg, G., Sejersen, T., and Kostareva, A. (2015) Various lamin A/C mutations alter expression profile of mesenchymal stem cells in mutation specific manner, Mol. Genet. Metab., 115, 118–127.
Perepelina, K., Dmitrieva, R., Ignatieva, E., Borodkina, A., Kostareva, A., and Malashicheva, A. (2018) Lamin A/C mutation associated with lipodystrophy influences adi–pogenic differentiation of stem cells through interaction with Notch signaling, Biochem. Cell Biol., 96, 342–348.
Perepelina, K. I., Smolina, N. A., Zabirnik, A. S., Dmitrieva, R. I., Malashicheva, A. B., and Kostareva, A. A. (2017) The role of LMNA mutations in myogenic differen–tiation of C2C12 and primary satellite cells, Cell Tissue Biol., 59, 117–124.
Bentzinger, C. F., Wang, Y. X., and Rudnicki, M. A. (2012) Building muscle: molecular regulation of myogenesis, Cold Spring Harbor Perspect. Biol., 4, a008342.
Hol, E. M., and Capetanaki, Y. (2017) Type III intermedi–ate filaments desmin, glial fibrillary acidic protein (GFAP), vimentin, and peripherin, Cold Spring Harbor Perspect. Biol., 9, a021642.
Capetanaki, Y., Milner, D. J., and Weitzer, G. (1997) Desmin in muscle formation and maintenance: knockouts and consequences, Cell Struct. Funct., 22, 103–116.
Holst, D., Luquet, S., Kristiansen, K., and Grimaldi, P. A. (2003) Roles of peroxisome proliferator–activated receptors delta and gamma in myoblast transdifferentiation, Exp. Cell Res., 288, 168–176.
Grimaldi, P. A., Teboul, L., Inadera, H., Gaillard, D., and Amri, E. Z. (1997) Trans–differentiation of myoblasts to adipoblasts: triggering effects of fatty acids and thiazo–lidinediones, Prostaglandins. Leukot. Essent. Fatty Acids, 57, 71–75.
Bosma, M. (2016) Lipid droplet dynamics in skeletal mus–cle, Exp. Cell Res., 340, 180–186.
MacPherson, R. E. K., Ramos, S. V., Vandenboom, R., Roy, B. D., and Peters, S. J. (2013) Skeletal muscle PLIN proteins, ATGL and CGI–58, interactions at rest and fol–lowing stimulated contraction, Am. J. Physiol. Regul. Integr. Comp. Physiol., 304, R644–R650.
Rankin, J., and Ellard, S. (2006) The laminopathies: a clin–ical review, Clin. Genet., 70, 261–274.
Shah, S. B., Davis, J., Weisleder, N., Kostavassili, I., McCulloch, A. D., Ralston, E., Capetanaki, Y., and Lieber, R. L. (2004) Structural and functional roles of desmin in mouse skeletal muscle during passive deformation, Biophys. J., 86, 2993–3008.
Ralston, E., Lu, Z., Biscocho, N., Soumaka, E., Mavroidis, M., Prats, C., Lomo, T., Capetanaki, Y., and Ploug, T. (2006) Blood vessels and desmin control the posi–tioning of nuclei in skeletal muscle fibers, J. Cell. Physiol., 209, 874–882.
Roman, W., Martins, J. P., Carvalho, F. A., Voituriez, R., Abella, J. V. G., Santos, N. C., Cadot, B., Way, M., and Gomes, E. R. (2017) Myofibril contraction and crosslink–ing drive nuclear movement to the periphery of skeletal muscle, Nat. Cell Biol., 19, 1189–1201.
Frock, R. L., Kudlow, B. A., Evans, A. M., Jameson, S. A., Hauschka, S. D., and Kennedy, B. K. (2006) Lamin A/C and emerin are critical for skeletal muscle satellite cell dif–ferentiation, Genes Dev., 20, 486–500.
Sorkina, E. L., Kalashnikova, M. F., Melnichenko, G. A., and Tyulpakov, A. N. (2015) Familial partial lipodystrophy (Dunnigan syndrome) as a consequence of mutation in the LMNA gene: the first description of clinical case in Russia, Terap. Arkhiv, 87, 83–87.
Author information
Authors and Affiliations
Corresponding author
Additional information
Russian Text © N. V. Khromova, K. I. Perepelina, O. A. Ivanova, A. B. Malashicheva, A. A. Kostareva, R. I. Dmitrieva, 2019, published in Biokhimiya, 2019, Vol. 84, No. 3, pp. 354–364.
Rights and permissions
About this article
Cite this article
Khromova, N.V., Perepelina, K.I., Ivanova, O.A. et al. R482L Mutation of the LMNA Gene Affects Dynamics of C2C12 Myogenic Differentiation and Stimulates Formation of Intramuscular Lipid Droplets. Biochemistry Moscow 84, 241–249 (2019). https://doi.org/10.1134/S0006297919030064
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297919030064